IP Library Granted Patent US 10,188,751
Granted Patent B2
US 10,188,751 · App. 14/558,301 · Granted Jan 29, 2019

Papillomavirus pseudoviruses for detection and therapy of tumors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,188,751
App. No.
14/558,301
Granted
Jan 29, 2019
Kind
B2
Abstract

Disclosed herein are methods of detecting tumors, monitoring cancer therapy, and selectively inhibiting the proliferation and/or killing of cancer cells utilizing a papilloma pseudovirus or a papilloma virus-like particle (VLP).

Claims (8)

1. A method comprising administering to cancer cells in a subject, a papilloma pseudovirus that comprises a fluorescent dye or a papilloma virus-like particle (VLP) that comprises a fluorescent dye, and exposing the fluorescent dye in the cancer cells in the subject to an excitation wavelength of light.

2. The method of claim 1 , wherein the fluorescent dye is chemically coupled to the pseudovirus or to the VLP.

3. The method of claim 2 , wherein the fluorescent dye is chemically coupled to the surface of the papilloma pseudovirus or to the surface of the papilloma VLP.

4. The method of claim 1 , wherein the papilloma pseudovirus or the papilloma VLP is administered to cancer cells in an eye in the subject.

5. A method comprising administering to cancer cells in an eye of a subject, a papilloma pseudovirus chemically coupled to a fluorescent dye or a papilloma virus-like particle (VLP) chemically coupled to a fluorescent dye, and exposing the fluorescent dye in the cancer cells in the subject to an excitation wavelength of light.

6. The method of claim 5 , wherein the fluorescent dye is chemically coupled to the surface of the papilloma pseudovirus or to the surface of the papilloma VLP.

7. The method of claim 1 , wherein the papilloma pseudovirus or the papilloma VLP is injected into the cancer cells in the subject.

8. The method of claim 1 , wherein the papilloma pseudovirus or the papilloma VLP is injected into cancer cells in an eye in the subject.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 11, 2018
From: ADVENT LIFE SCIENCES FUND I, L.P.
To: AURA BIOSCIENCES, INC.
Reel/Frame 044593/0304 →
SECURITY INTEREST Recorded Sep 26, 2016
From: AURA BIOSCIENCES, INC.
To: ADVENT LIFE SCIENCES FUND I, L.P.
Reel/Frame 039851/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: ROBERTS, JEFF; LOWY, DOUGLAS R.; SCHILLER, JOHN T.
To: THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
Reel/Frame 038814/0250 →